ResMed Inc (ASX: RMD) Share Price and News
Price
$39.40
Movement
0.55 (+1.42%)
As at 4 Jul - Closed (20 mins delayed)
52 Week Range
$28.155 - $40.75
1 Year Return
+38.59%
ResMed Inc Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Earnings Yield
3.44%
Franking
-
Dividend per share
0.33
Year To Date Return
7.61%
Shares Outstanding
1.47 billion
Earnings per share
0.891
Share Price
$39.40
Day Change
0.55 (+1.42%)
52 Week Range
$28.155 - $40.75
Yesterday's Close
$38.85
Today's Open
$39.25
Days Range
$39.07 - $39.46
Volume
432,948
Avg. Volume (1 month)
859,502
Turnover
$17,032,404
As at 4 Jul - Closed
ResMed Inc (ASX: RMD)
Latest News
Share Market News
Pro Medicus shares surge 10% to crack $300 as healthcare leads ASX 200 sectors
Broker Notes
Bell Potter names more of the best ASX 200 stocks to buy in July
Growth Shares
3 no-brainer ASX shares to buy with $200 right now
Healthcare Shares
These healthcare stocks could be set to double according to broker
Broker Notes
10 Aussie stocks to buy in FY 2026
How to invest
How to make $5,000 a month in passive income
How to invest
How you could turn $10k into $100k with ASX shares
Broker Notes
5 ASX 200 shares for smart investors to buy in July
How to invest
How to earn a $500 monthly second income from ASX shares
Broker Notes
All about the momentum: Which ASX 200 stocks does Macquarie currently favour?
Blue Chip Shares
5 ASX 200 blue chip shares to buy in FY26 with $5,000
Growth Shares
Where to invest $50,000 in ASX shares
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
About ResMed Inc
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.